The global tumor ablation market is moderately competitive with various global as well as local market players. As of 2015, the global tumor ablation market was dominated by Medtronic, plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.),and Boston Scientific Corporation (U.S.) that together accounted for...
More...
